January 01, 2026 a 08:00 am
VTRS: Fundamental Ratio Analysis - Viatris Inc.
Viatris Inc. operates in the healthcare sector, providing a broad spectrum of pharmaceutical products aimed at numerous therapeutic areas. Despite facing a competitive environment, Viatris has shown resilience and potential for stable growth. While the company’s recent performance has some challenges, its diversified portfolio offers promising opportunities for long-term investors.
Fundamental Rating
The current fundamental analysis of Viatris Inc. indicates a moderate overall performance, with varied results across different financial metrics.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 5 | |
| Return on Equity | 1 | |
| Return on Assets | 1 | |
| Debt to Equity | 1 | |
| Price to Earnings | 1 | |
| Price to Book | 4 |
Historical Rating
Historical data indicates a consistent scoring trend, with only slight variations observed over time.
| Date | Overall Score | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | 2 | 5 | 1 | 1 | 1 | 1 | 4 |
Analyst Price Targets
Analyst projections place Viatris Inc.'s stock within a narrow price band, reflecting consensus on its stability.
| High | Low | Median | Consensus |
|---|---|---|---|
| 15 | 15 | 15 | 15 |
Analyst Sentiment
Analysts maintain a mainly "Hold" recommendation, indicating neutral market sentiment with cautious optimism.
| Recommendation | Count | Visualization |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 1 | |
| Hold | 8 | |
| Sell | 2 | |
| Strong Sell | 0 |
Conclusion
Viatris Inc., while faced with certain financial challenges, remains a key player in the healthcare sector with a diverse product portfolio. Its stable price targets and neutral analyst sentiment suggest cautious optimism. Investors may find potential value in Viatris’s extensive reach and strong industry presence. However, awareness of financial metrics and market competition remains paramount. Ultimately, Viatris presents a balanced investment profile with opportunities and inherent risks for informed stakeholders.